alloxan has been researched along with Atherogenesis in 10 studies
Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.
Excerpt | Relevance | Reference |
---|---|---|
" We histologically assessed the atherosclerotic lesion development, cellular content, pimonidazole positive-hypoxic area, the nuclear localization of hypoxia-inducible factor-1α, and apoptosis." | 7.85 | Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits. ( Asada, Y; Iwakiri, T; Kawai, K; Kitamura, K; Koshimoto, C; Kuge, Y; Matsuura, Y; Sugita, C; Tamaki, N; Yamasaki, K; Yamashita, A; Zhao, S; Zhao, Y, 2017) |
"Experiments were undertaken to ascertain whether the previously demonstrated inhibition of the development of experimental aortic atherosclerosis in alloxan-diabetic rabbits fed cholesterol was due to the injection of alloxan per se or to the existence of the diabetic state produced by alloxan." | 7.63 | The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. IV. The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit. ( BRECHIN, DJ; DUFF, GL; FINKELSTEIN, WE, 1954) |
" We histologically assessed the atherosclerotic lesion development, cellular content, pimonidazole positive-hypoxic area, the nuclear localization of hypoxia-inducible factor-1α, and apoptosis." | 3.85 | Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits. ( Asada, Y; Iwakiri, T; Kawai, K; Kitamura, K; Koshimoto, C; Kuge, Y; Matsuura, Y; Sugita, C; Tamaki, N; Yamasaki, K; Yamashita, A; Zhao, S; Zhao, Y, 2017) |
"Experiments were undertaken to ascertain whether the previously demonstrated inhibition of the development of experimental aortic atherosclerosis in alloxan-diabetic rabbits fed cholesterol was due to the injection of alloxan per se or to the existence of the diabetic state produced by alloxan." | 3.63 | The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. IV. The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit. ( BRECHIN, DJ; DUFF, GL; FINKELSTEIN, WE, 1954) |
"Alloxan was used to induce diabetes in male Watanabe heritable hyperlipidemic (WHHL) rabbits that were sacrificed 2 and 6 months after the induction of diabetes." | 1.33 | VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. ( Ahtialansaari, T; Babu, M; Bhardwaj, S; Hakumaki, J; Herzig, KH; Kokina, I; Laakso, M; Laitinen, T; Roy, H; Uotila, S; Ylä-Herttuala, S, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Elseweidy, MM | 1 |
Elnagar, GM | 1 |
M Elsawy, M | 1 |
Ali, AA | 1 |
Zein, N | 1 |
Oršolić, N | 1 |
Sirovina, D | 1 |
Odeh, D | 1 |
Gajski, G | 1 |
Balta, V | 1 |
Šver, L | 1 |
Jazvinšćak Jembrek, M | 1 |
Matsuura, Y | 1 |
Yamashita, A | 1 |
Zhao, Y | 1 |
Iwakiri, T | 1 |
Yamasaki, K | 1 |
Sugita, C | 1 |
Koshimoto, C | 1 |
Kitamura, K | 1 |
Kawai, K | 1 |
Tamaki, N | 1 |
Zhao, S | 1 |
Kuge, Y | 1 |
Asada, Y | 1 |
DUFF, GL | 3 |
McMILLAN, GC | 1 |
Gupta, S | 1 |
Sharma, SB | 1 |
Prabhu, KM | 1 |
COOK, DL | 1 |
MILLS, LM | 1 |
GREEN, DM | 1 |
BRECHIN, DJ | 1 |
FINKELSTEIN, WE | 1 |
PAYNE, TP | 1 |
Dhar, P | 1 |
Bhattacharyya, D | 1 |
Bhattacharyya, DK | 1 |
Ghosh, S | 1 |
Roy, H | 1 |
Bhardwaj, S | 1 |
Babu, M | 1 |
Kokina, I | 1 |
Uotila, S | 1 |
Ahtialansaari, T | 1 |
Laitinen, T | 1 |
Hakumaki, J | 1 |
Laakso, M | 1 |
Herzig, KH | 1 |
Ylä-Herttuala, S | 1 |
10 other studies available for alloxan and Atherogenesis
Article | Year |
---|---|
Losartan and azelastine either alone or in combination as modulators for endothelial dysfunction and platelets activation in diabetic hyperlipidemic rats.
Topics: Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Blood Platelets; Diabete | 2020 |
Efficacy of Caffeic Acid on Diabetes and Its Complications in the Mouse.
Topics: Alloxan; Animals; Antioxidants; Apoptosis; Atherosclerosis; Blood Glucose; Caffeic Acids; Diabetes C | 2021 |
Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits.
Topics: Alloxan; Animals; Apoptosis; Atherosclerosis; Autoradiography; Body Weight; Cluster Analysis; Diabet | 2017 |
The inhibition of experimental cholesterol atherosclerosis by alloxan diabetes in the rabbit.
Topics: Alloxan; Animals; Atherosclerosis; Cholesterol; Diabetes Mellitus, Experimental; Humans; Rabbits | 1948 |
Ameliorative effect of Cassia auriculata L. leaf extract on glycemic control and atherogenic lipid status in alloxan-induced diabetic rabbits.
Topics: Alloxan; Animals; Atherosclerosis; Blood Glucose; Cassia; Cholesterol, HDL; Cholesterol, LDL; Diabet | 2009 |
The mechanism of alloxan protection in experimental atherosclerosis.
Topics: Alloxan; Animals; Arteriosclerosis; Atherosclerosis; Cholesterol; Diabetes Mellitus, Experimental; L | 1954 |
The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. IV. The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit.
Topics: Alloxan; Animals; Arteriosclerosis; Atherosclerosis; Blood Glucose; Cholesterol; Diabetes Mellitus, | 1954 |
The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. III. The mechanism of the inhibition of experimental cholesterol atherosclerosis in alloxan-diabetic rabbits.
Topics: Alloxan; Animals; Aorta; Arteriosclerosis; Atherosclerosis; Blood Glucose; Cholesterol; Diabetes Mel | 1950 |
Dietary comparison of conjugated linolenic acid (9 cis, 11 trans, 13 trans) and alpha-tocopherol effects on blood lipids and lipid peroxidation in alloxan-induced diabetes mellitus in rats.
Topics: Alloxan; alpha-Tocopherol; Animals; Atherosclerosis; Diabetes Mellitus, Experimental; Diet; Erythroc | 2006 |
VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits.
Topics: Alloxan; Animals; Atherosclerosis; Diabetes Mellitus, Experimental; Disease Models, Animal; Hyperlip | 2006 |